{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:37:19Z","timestamp":1792705039109,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM20\/00186"],"award-info":[{"award-number":["CM20\/00186"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP15\/00007"],"award-info":[{"award-number":["CP15\/00007"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CPII20\/00026"],"award-info":[{"award-number":["CPII20\/00026"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI20\/00210"],"award-info":[{"award-number":["FI20\/00210"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/01870"],"award-info":[{"award-number":["PI16\/01870"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01446"],"award-info":[{"award-number":["PI19\/01446"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PT20\/00009"],"award-info":[{"award-number":["PT20\/00009"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD21\/0002\/0025"],"award-info":[{"award-number":["RD21\/0002\/0025"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008061","name":"Fundacion Mutua Madrilena","doi-asserted-by":"publisher","award":["MMA 2018"],"award-info":[{"award-number":["MMA 2018"]}],"id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008061","name":"Fundacion Mutua Madrilena","doi-asserted-by":"publisher","award":["MMA 2020"],"award-info":[{"award-number":["MMA 2020"]}],"id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["FPU17\/01706"],"award-info":[{"award-number":["FPU17\/01706"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Fundaci\u00f3n Ram\u00f3n Areces","doi-asserted-by":"publisher","award":["MMA 2018 & MMA 2020"],"award-info":[{"award-number":["MMA 2018 & MMA 2020"]}],"id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011100","name":"Fundaci\u00f3n Espa\u00f1ola para la Ciencia y la Tecnolog\u00eda","doi-asserted-by":"publisher","award":["PRECIPITA PR250"],"award-info":[{"award-number":["PRECIPITA PR250"]}],"id":[{"id":"10.13039\/501100011100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018946","name":"Servicio Gallego de Salud","doi-asserted-by":"publisher","award":["1.40\u2009\u00b5M"],"award-info":[{"award-number":["1.40\u2009\u00b5M"]}],"id":[{"id":"10.13039\/501100018946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018946","name":"Servicio Gallego de Salud","doi-asserted-by":"publisher","award":["3.00\u2009\u00b5M"],"award-info":[{"award-number":["3.00\u2009\u00b5M"]}],"id":[{"id":"10.13039\/501100018946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018946","name":"Servicio Gallego de Salud","doi-asserted-by":"publisher","award":["CLI-095"],"award-info":[{"award-number":["CLI-095"]}],"id":[{"id":"10.13039\/501100018946","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.biopha.2022.113671","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T12:56:30Z","timestamp":1662987390000},"page":"113671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Repurposing drugs to inhibit innate immune responses associated with TLR4, IL1, and NLRP3 signaling in joint cells"],"prefix":"10.1016","volume":"155","author":[{"given":"Eloi","family":"Franco-Trepat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Guill\u00e1n-Fresco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Alonso-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"L\u00f3pez-Fag\u00fandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Pazos-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antia","family":"Crespo-Golmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreste","family":"Gualillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Jorge-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana Bel\u00e9n","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113671_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/ket346","article-title":"Defining and mapping the person with osteoarthritis for population studies and public health","volume":"53","author":"Thomas","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.biopha.2022.113671_bib2","unstructured":"World Health Organization Disease incidence, prevalence and disability. Glob. Burd. Dis. 2004 Updat. 2004, 3, 28\u201337."},{"key":"10.1016\/j.biopha.2022.113671_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/rheumatology\/ket463","article-title":"Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries","volume":"53","author":"Kingsbury","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.biopha.2022.113671_bib4","first-page":"1","article-title":"TLR4 signalling in osteoarthritis-finding targets for candidate DMOADs","volume":"11","author":"G\u00f3mez","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.biopha.2022.113671_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.joca.2009.08.010","article-title":"Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis","volume":"18","author":"Blagojevic","year":"2010","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.biopha.2022.113671_bib6","first-page":"19","article-title":"Molecular mechanisms underlying osteoarthritis development: Notch and NF-\u039aB","author":"Saito","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2022.113671_bib7","article-title":"Osteoarthritis: Current Molecular Biomarkers and the Way Forward","author":"Kraus","year":"2020","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.biopha.2022.113671_bib8","first-page":"8","article-title":"Classification of four distinct osteoarthritis subtypes with a knee joint tissue transcriptome atlas","author":"Yuan","year":"2020","journal-title":"Bone Res."},{"key":"10.1016\/j.biopha.2022.113671_bib9","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.113671_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1515\/bmc-2019-0014","article-title":"Advances in molecular biomarker for early diagnosis of Osteoarthritis","volume":"10","author":"Munjal","year":"2019","journal-title":"BioMol. Concepts"},{"key":"10.1016\/j.biopha.2022.113671_bib11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrrheum.2010.159","article-title":"The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis","volume":"6","author":"Sellam","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.biopha.2022.113671_bib12","first-page":"20","article-title":"Regulatory effects and interactions of the Wnt and OPG-RANKL-RANK signaling at the bone-cartilage interface in osteoarthritis","author":"Kov\u00e1cs","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113671_bib13","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/annrheumdis-2016-210815","article-title":"EULAR recommendations for the use of imaging in the clinical management of peripheral joint osteoarthritis","volume":"76","author":"Sakellariou","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2022.113671_bib14","first-page":"9","article-title":"Efficacy of low-level laser therapy on pain and disability in knee osteoarthritis: systematic review and meta-analysis of randomised placebo-controlled trials","author":"Stausholm","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.biopha.2022.113671_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2020.100059","article-title":"Disease modification in osteoarthritis; pathways to drug approval","volume":"2","author":"Katz","year":"2020","journal-title":"Osteoarthr. Cartil. Open"},{"key":"10.1016\/j.biopha.2022.113671_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bcp.2019.02.037","article-title":"Osteoarthritis phenotypes and novel therapeutic targets","volume":"165","author":"Van Spil","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113671_bib17","first-page":"135","article-title":"Disease modification in osteoarthritis: are we there yet?","volume":"37","author":"Oo","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.biopha.2022.113671_bib18","doi-asserted-by":"crossref","unstructured":"Chittepu, V.C.S.R.; Kalhotra, P.; Osorio-Gallardo, T.; Gallardo-Vel\u00e1zquez, T.; Osorio-Revilla, G. pharmaceutics Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study. Pharmaceutics 2019, 11, 238, doi:10.3390\/pharmaceutics11050238.","DOI":"10.3390\/pharmaceutics11050238"},{"key":"10.1016\/j.biopha.2022.113671_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2019.06.014","article-title":"Drug repurposing: a promising tool to accelerate the drug discovery process","author":"Parvathaneni","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2022.113671_bib20","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.113671_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.intimp.2019.01.049","article-title":"Oridonin inhibits IL-1\u03b2-induced inflammation in human osteoarthritis chondrocytes by activating PPAR-\u03b3","volume":"69","author":"Jia","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2022.113671_bib22","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nm.3143","article-title":"Inhibition of TGF-\u03b2 signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis","volume":"19","author":"Zhen","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2022.113671_bib23","doi-asserted-by":"crossref","unstructured":"Okura, T.; Matsushita, M.; Mishima, K.; Esaki, R.; Seki, T.; Ishiguro, N.; Kitoh, H. Activated FGFR3 prevents subchondral bone sclerosis during the development of osteoarthritis in transgenic mice with achondroplasia. J. Orthop. Res. 36, 300\u2013308, doi:10.1002\/jor.23608.","DOI":"10.1002\/jor.23608"},{"key":"10.1016\/j.biopha.2022.113671_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10522-019-09808-3","article-title":"The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging","volume":"20","author":"Teissier","year":"2019","journal-title":"Biogerontology"},{"key":"10.1016\/j.biopha.2022.113671_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/08830185.2017.1397656","article-title":"TLRs\/NLRs: shaping the landscape of host immunity","volume":"37","author":"Dolasia","year":"2018","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.biopha.2022.113671_bib26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3389\/fphys.2018.00504","article-title":"Role of toll-like receptor 4 on osteoblast metabolism and function","volume":"9","author":"Alonso-P\u00e9rez","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2022.113671_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11010-017-3078-x","article-title":"Increased expression of damage-associated molecular patterns (DAMPs) in osteoarthritis of human knee joint compared to hip joint","volume":"436","author":"Rosenberg","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2022.113671_bib28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00011-020-01326-0","article-title":"Novel adipokine associated with OA: retinol binding protein 4 (RBP4) is produced by cartilage and is correlated with MMPs in osteoarthritis patients","volume":"69","author":"Scotece","year":"2020","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.biopha.2022.113671_bib29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41467-017-00726-x","article-title":"Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.113671_bib30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/ard.2010.132399","article-title":"Expanding the adipokine network in cartilage: identification and regulation of novel factors in human and murine chondrocytes","volume":"70","author":"Conde","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2022.113671_bib31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3892\/ijmm.2017.2885","article-title":"Resveratrol inhibits the IL-1\u03b2-induced expression ofMMP-13 and IL-6 in human articular chondrocytes viaTLR4\/MyD88-dependent and-independent signaling cascades","volume":"39","author":"Gu","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2022.113671_bib32","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/jcm8081178","article-title":"Visfatin connection: present and future in osteoarthritis and osteoporosis","volume":"8","author":"Franco-Trepat","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2022.113671_bib33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/bph.15707","article-title":"Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: preclinical and clinical evidence in osteoarthritis and gout","volume":"179","author":"Franco-Trepat","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113671_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1155\/2010\/674363","article-title":"Targeting TLR\/IL-1R signalling in human diseases","volume":"2010","author":"Loiarro","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2022.113671_bib35","first-page":"8","article-title":"Il-1 in osteoarthritis: time for a critical review of the literature","author":"Vincent","year":"2019","journal-title":"F1000Research"},{"key":"10.1016\/j.biopha.2022.113671_bib36","first-page":"38","article-title":"Acute intervention with selective interleukin-1 inhibitor therapy may reduce the progression of posttraumatic osteoarthritis of the knee: a systematic review of current evidence","author":"Aman","year":"2022","journal-title":"Arthroscopy"},{"key":"10.1016\/j.biopha.2022.113671_bib37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/BOR.0000000000000143","article-title":"Interleukin-1 as a therapeutic target in gout","volume":"27","author":"Dumusc","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.biopha.2022.113671_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-018-0739-z","article-title":"Therapy for CPPD: options and evidence","volume":"20","author":"Andr\u00e9s","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.biopha.2022.113671_bib39","first-page":"37","article-title":"TAK-242, a small-molecule inhibitor of Toll-like receptor 4 signalling, unveils similarities and differences in lipopolysaccharide- and lipid-induced inflammation and insulin resistance in muscle cells","volume":"33","author":"Hussey","year":"2012","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biopha.2022.113671_bib40","doi-asserted-by":"crossref","unstructured":"Villalvilla, A.; Silva, A.; Largo, R.; Gualillo, O. 6-Shogaol inhibits chondrocytes \u2019 innate immune responses and cathepsin-K activity. 2014, 256\u2013266, doi:10.1002\/mnfr.201200833.","DOI":"10.1002\/mnfr.201200833"},{"key":"10.1016\/j.biopha.2022.113671_bib41","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.113671_bib42","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nsmb.2260","article-title":"Structure of the activating IL-1 receptor signaling complex","volume":"19","author":"Thomas","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.biopha.2022.113671_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Software news and update AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.biopha.2022.113671_bib44","unstructured":"Federal Drug Agency (FDA) The Clinical Use of Naloxone."},{"key":"10.1016\/j.biopha.2022.113671_bib45","unstructured":"Federal Drug Agency (FDA) Thalomid - FDA prescribing information, side effects and uses Available online: https:\/\/www.drugs.com\/pro\/thalomid.html#S5.1 (accessed on Jun 8, 2022)."},{"key":"10.1016\/j.biopha.2022.113671_bib46","doi-asserted-by":"crossref","DOI":"10.1097\/SCS.0000000000002527","article-title":"Therapeutic Effects of Sildenafil on Experimental Mandibular Fractures","volume":"27","author":"\u00c7akir-\u00d6zkan","year":"2016","journal-title":"J. Craniofac. Surg."},{"key":"10.1016\/j.biopha.2022.113671_bib47","doi-asserted-by":"crossref","unstructured":"Bustin, S.A.; Benes, V.; Garson, J.A.; Hellemans, J.; Huggett, J.; Kubista, M.; Mueller, R.; Nolan, T.; Pfaffl, M.W.; Shipley, G.L.; et al. The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments. 2009, doi:10.1373\/clinchem.2008.112797.","DOI":"10.1373\/clinchem.2008.112797"},{"key":"10.1016\/j.biopha.2022.113671_bib48","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.1002\/jcp.27723","article-title":"Cholinergic activity regulates the secretome of epicardial adipose tissue: association with atrial fibrillation","volume":"234","author":"Couselo\u2010Seijas","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2022.113671_bib49","first-page":"212","article-title":"Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers","author":"del Pilar Chantada-V\u00e1zquez","year":"2020","journal-title":"J. Proteom."},{"key":"10.1016\/j.biopha.2022.113671_bib50","first-page":"6","article-title":"A novel community driven software for functional enrichment analysis of extracellular vesicles data","author":"Pathan","year":"2017","journal-title":"J. Extracell. Vesic."},{"key":"10.1016\/j.biopha.2022.113671_bib51","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00109-018-1691-0","article-title":"NLRP3 deficiency accelerates pressure overload-induced cardiac remodeling via increased TLR4 expression","volume":"96","author":"Li","year":"2018","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.biopha.2022.113671_bib52","first-page":"24","article-title":"Mass spectrometry-based proteomics identify novel serum osteoarthritis biomarkers","author":"Tardif","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2022.113671_bib53","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1002\/art.22848","article-title":"Inhibition of toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis","volume":"56","author":"Abdollahi-Roodsaz","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2022.113671_bib54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mehy.2016.04.039","article-title":"Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation","volume":"92","author":"Demidowich","year":"2016","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.biopha.2022.113671_bib55","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.gene.2013.04.039","article-title":"Innate immunity functional gene polymorphisms and gout susceptibility","volume":"524","author":"Qing","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.biopha.2022.113671_bib56","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/1573397117666211116111738","article-title":"Emerging and new treatment options for knee osteoarthritis","volume":"18","author":"Siddiq","year":"2021","journal-title":"Curr. Rheumatol. Rev."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222010605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222010605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:24:20Z","timestamp":1781781860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222010605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":56,"alternative-id":["S0753332222010605"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113671","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing drugs to inhibit innate immune responses associated with TLR4, IL1, and NLRP3 signaling in joint cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113671"}}